Trial · NCT01656434
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who Experienced At Least One Adverse Event | NOMAC-E2 | 41.2 | Percentage of Participants | ||
| Percentage of Participants Who Experienced At Least One Adverse Event | NETA-EE | 45.2 | Percentage of Participants | ||
| Number of Participants Who Experience at Least One Venous or Arterial Thrombotic/Thromboembolic Event | NOMAC-E2 | 0 | Participants | ||
| Number of Participants Who Experience at Least One Venous or Arterial Thrombotic/Thromboembolic Event | NETA-EE | 1 | Participants | ||
| Change From Baseline in Body Weight | NOMAC-E2 | After Cycle 3 (n=2135; n=527) | 0.14 | Standard Error 0.14 | kilograms |
| Change From Baseline in Body Weight | NETA-EE | After Cycle 3 (n=2135; n=527) | 0.41 | Standard Error 0.24 | kilograms |
| Change From Baseline in Body Weight | NOMAC-E2 | After Cycle 6 (n=1809; n=459) | 0.64 | Standard Error 0.18 | kilograms |
| Change From Baseline in Body Weight | NETA-EE | After Cycle 6 (n=1809; n=459) | 0.29 | Standard Error 0.28 | kilograms |
| Change From Baseline in Body Weight | NOMAC-E2 | After Cycle 9 (n=1468; n=391) | 1.21 | Standard Error 0.23 | kilograms |
| Change From Baseline in Body Weight | NETA-EE | After Cycle 9 (n=1468; n=391) | 0.32 | Standard Error 0.35 | kilograms |
| Change From Baseline in Body Weight | NOMAC-E2 | After Cycle 13 (n=462; n=145) | 1.57 | Standard Error 0.29 | kilograms |
| Change From Baseline in Body Weight | NETA-EE | After Cycle 13 (n=462; n=145) | 0.90 | Standard Error 0.46 | kilograms |
| Change From Baseline in Body Weight | NOMAC-E2 | Last In-Treatment Measurement (n=2231; n=549) | 1.39 | Standard Error 0.17 | kilograms |
| Change From Baseline in Body Weight | NETA-EE | Last In-Treatment Measurement (n=2231; n=549) | 0.75 | Standard Error 0.29 | kilograms |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01656434/results